<DOC>
	<DOCNO>NCT02536105</DOCNO>
	<brief_summary>The purpose study evaluate association blood drug level correspond score commonly use behavioral instrument base upon data collect follow administration three different methylphenidate hydrochloride extended-release drug product child ADHD .</brief_summary>
	<brief_title>PK/PD Pediatric ADHD Classroom Study</brief_title>
	<detailed_description>This randomize , double-blind , 4-treatment 4-period crossover study conduct school laboratory environment evaluate hour-by-hour behavioral instrument score hour-by-hour PK 3 different extended-release MPH formulation well placebo child ADHD . The complete study consist three period : Screening , Dose Titration Double-Blind Crossover Laboratory Classroom . The double-blind phase consist four period ( four week ) : week consist blind administration one three active methylphenidate hydrochloride treatment placebo Sunday Saturday . On last day period ( Saturday ) , study participant evaluate laboratory classroom set . On Saturdays , blind dos study drug administer school site study staff morning test laboratory classroom day . On day , medication take morning home .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>1 . Male female outpatient 2 . Ages 612 year time screen 3 . Judged investigator physically healthy suitable participation study 4 . Diagnosis DSM5ADHD combine , predominantly inattentive hyperactive/impulsive presentation , per clinical evaluation confirm MINIKID 5 . Clinical Global ImpressionsSeverity ( CGIS ) ≥ 3 6 . ≥ 90th percentile normative value gender age ADHD RSIV total score screen baseline 7 . Study participant parent/legal guardian willing able give write informed consent him/her participate study 8 . Study participant must able give assent participate trial 9 . Study participant legal guardian must able speak understand English 10 . Able tolerate multiple finger prick 11 . Willing comply study procedures 1 . Current ( last month ) psychiatric diagnosis specific phobia , motor skill disorder , oppositional defiant disorder , sleep disorder , elimination disorder , adjustment disorder , learn disorder , communication disorder . Participants school phobia separation anxiety eligible 2 . Cognitively impaired , investigator 's opinion 3 . Any clinically significant chronic medical condition , judgment investigator , may interfere participant 's ability participate study 4 . Seizure disorder exclude history febrile seizures 5 . Thyroid disease 6 . Tourette 's disorder chronic tic disorder ( mild medication induce tic allow ) 7 . Serious cardiac condition include cardiomyopathy , serious arrhythmia , structural cardiac disorder , severe hypertension 8 . Glaucoma 9 . Current recent ( within past 6 month ) DSM5 drug dependence substance abuse ( exclude nicotine caffeine ) 10 . Pregnant nursing female . Females must negative urine pregnancy test screen well four additional visit must abstinent use adequate reliable contraception throughout study 11 . Currently treat satisfied ADHD medication 12 . Current psychotropic medication sedative hypnotic sleep 13 . Use atomoxetine , clonidine , guanfacine monoamine oxidase inhibitor within 28 day baseline visit 14 . Participation another investigational medication study within 30 day prior screen 15 . Clinically significant abnormal laboratory result , electrocardiogram ( ECG ) result , physical examination , vital sign screen investigator considers inappropriate allow participation study 16 . Planned use prohibit drug baseline visit end trial 17 . History allergic reaction know suspected sensitivity substance contain study drug 18 . Food allergy determine PI severe easily accommodate study 19 . Inability swallow study medication</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>ADHD</keyword>
</DOC>